Teva Pharmaceutical Industries Ltd TEVA reported a 6.7% rise in its first-quarter net income. The company also affirmed its projections for the full year.
The company's profit increased to $761 million, or $0.84 per share, versus $713 million, or $0.79 per share, in the year-ago period. The company's adjusted net rose to $1.04 per share from $0.91 per share. The company's shares outstanding dropped 2.1% to 902 million. Its sales climbed 12% to $4.08 billion. However, analysts were expecting earnings of $1.04 per share on sales of $4.28 billion. TEVA's sales in Europe increased 66% while sales in North America dropped 11%.
TEVA projects 2011 adjusted earnings of $4.90 to $5.20 per share on revenue of $18.5 billion to $19 billion. However, analysts were projecting earnings of $5.07 per share on revenue of $18.74 billion.
TEVA shares gained 0.32% to $47.29 in after-hours trading.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in